{"chunk_type":"transcript_chunk","text":"# Thoracic Surgery Physics Framework + Perioperative Respiratory Timeline\n## Pre-op Optimization\n- 폐수술 전 핵심은 anatomy 암기보다 pressure-volume physiology를 임상 결정에 연결하는 것.\n- **Smoking cessation:** 최소 4-8주 전 금연이 postoperative pulmonary complication 감소에 유리.\n- **Pulmonary reserve:** FEV1, DLCO로 baseline 평가 후 borderline이면 predicted postoperative function 계산(V/Q 기반).\n\n## Post-op Hypoxemia Timeline\n- immediate: airway obstruction/잔류 약물 효과 우선 평가.\n- day 2-3: atelectasis 가능성 높음(통증으로 shallow breathing).\n- day 3-5: pneumonia 감별(발열, purulent sputum, inflammatory signs).\n\n## Atelectasis Core Management\n- aggressive pain control + incentive spirometry + 필요 시 CPAP.\n- imaging에서 volume loss와 mediastinal pull 소견 확인.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-252","focus_area":"Thoracic Surgery Periop Framework","tags":["usmle-step2","surgery","pulmonology","perioperative","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Blunt Chest Trauma + Structural Failure Management\n## Trauma Triage\n- unstable trauma는 imaging 지연 없이 resuscitation/eFAST/OR 우선.\n- stable trauma는 CT 기반 손상 지도화.\n\n## High-yield Injuries\n- **Rib fractures (elderly):** pain control 실패 시 atelectasis/pneumonia 위험 증가.\n- **Flail chest:** paradoxical motion, severe case에서 PPV가 pneumatic splint 역할.\n- **Pulmonary contusion:** 6-24시간 후 악화 가능, fluid overload를 피하고 폐부종 악화 방지.\n- **Hemothorax:** chest tube 우선, massive output면 thoracotomy 기준 적용.\n- **Tracheobronchial injury:** persistent air leak + non-expanding lung이면 bronchoscopy로 확인 후 수술.\n\n## Additional emergency pearls\n- major hemoptysis는 airway 우선 확보하고 bleeding lung dependent positioning.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-272","focus_area":"Blunt Chest Trauma Management","tags":["usmle-step2","trauma","pulmonology","diagnosis","treatment","emergency"]}
{"chunk_type":"transcript_chunk","text":"# Diaphragmatic Injury + Rapid Trauma Recap Table\n## Diaphragmatic Rupture/Paralysis\n- blunt trauma 후 bowel sounds in chest면 diaphragmatic rupture 강하게 의심.\n- NG tube tip이 thorax로 올라가는 tube sign은 진단 단서.\n- phrenic nerve injury는 elevated hemidiaphragm + sniff test paradoxical movement로 확인.\n\n## Rapid Fire Table\n| 상황 (Scenario) | 진단/상태 | 핵심 조치 (Key Action) |\n| --- | --- | --- |\n| 수술 전 흡연자 | 폐합병증 위험 | 최소 4-8주 금연 |\n| 수술 전 낮은 FEV1 | 수술 위험평가 필요 | predicted postop function 계산 |\n| 수술 후 2-3일 저산소증 | Atelectasis 가능성 | pain control + incentive spirometry |\n| 수술 후 3-5일 발열/농성가래 | Pneumonia 가능성 | 항생제 및 감염평가 |\n| 역설적 흉벽운동 | Flail chest | 통증조절, 필요 시 PPV |\n| 지연성 침윤 악화 | Pulmonary contusion | fluid strategy 보수적 적용 |\n| large chest tube blood output | Massive hemothorax | thoracotomy 기준 적용 |\n| persistent large air leak | Bronchial rupture | bronchoscopy + 수술 |\n| chest bowel sounds | Diaphragmatic rupture | surgical repair |\n| elevated hemidiaphragm post-op | Diaphragmatic paralysis | sniff test 확인 |","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-292","focus_area":"Diaphragmatic Injury and Trauma Recap","tags":["usmle-step2","trauma","surgery","table","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Administrative Episode Index (Non-learning Source)\n이 줄은 에피소드 목록 메타데이터이며 학습용 의학 콘텐츠가 아님.\n- 데이터 무결성 유지를 위해 보존.\n- 학습 피드에서는 제외(exclude-feed).","subject":"DIP 2ec46f2986ee8056a3cedf522b3f7170","page_title":"DIP 2ec46f2986ee8056a3cedf522b3f7170","episode":"DIP 2ec46f2986ee8056a3cedf522b3f7170","section_path":["DIP 2ec46f2986ee8056a3cedf522b3f7170"],"source_doc_id":"DIP 2ec46f2986ee8056a3cedf522b3f7170","source_page":null,"source_anchor":"DIP 2ec46f2986ee8056a3cedf522b3f7170-1","focus_area":"Administrative Episode Index 1","tags":["usmle-step2","meta","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"# Administrative Episode Index Continuation (Non-learning Source)\n이 줄은 강의 목록/카테고리 인덱스 메타데이터입니다.\n- 임상 개념/진단/치료 정보가 없어 학습 노출에서 제외.\n- 데이터 추적용으로만 유지.","subject":"DIP 2ec46f2986ee8056a3cedf522b3f7170","page_title":"DIP 2ec46f2986ee8056a3cedf522b3f7170","episode":"DIP 2ec46f2986ee8056a3cedf522b3f7170","section_path":["DIP 2ec46f2986ee8056a3cedf522b3f7170"],"source_doc_id":"DIP 2ec46f2986ee8056a3cedf522b3f7170","source_page":null,"source_anchor":"DIP 2ec46f2986ee8056a3cedf522b3f7170-21","focus_area":"Administrative Episode Index 2","tags":["usmle-step2","meta","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"# UTI Management Master Table\n## Core Treatment Table\n| 진단명 | 대상 | 1차 치료 | 기간 | 핵심 포인트 |\n| --- | --- | --- | --- | --- |\n| ASB | 일반인/노인/도뇨관 | 치료하지 않음 | - | 불필요한 항생제로 내성 증가 |\n| ASB | 임산부/비뇨기 시술 전 | nitrofurantoin 또는 cephalosporin 계열 | 4-7일 | 산과 합병증 예방 목적 치료 |\n| Uncomplicated cystitis | 건강한 비임신 여성 | nitrofurantoin/fosfomycin/TMP-SMX | 대개 3-5일 | 짧은 코스 가능 |\n| Complicated cystitis | 남성/구조적 이상 등 | culture-guided regimen(예: FQ 포함) | 보통 더 길게 | 원인 교정 동반 |\n| Pyelonephritis (mild) | 안정 환자 | 경구 regimen 가능 | 상황별 | 외래 가능성 평가 |\n| Pyelonephritis (complicated/pregnancy) | 고위험군 | IV therapy 후 단계적 전환 | 대개 장기 | 입원 및 합병증 감시 |\n\n## Exam pearls\n- sterile pyuria는 STI(예: chlamydia/gonorrhea) 감별 필요.\n- male UTI는 complicated로 접근.\n- recurrent UTI는 trigger-targeted prophylaxis 전략 고려.","subject":"UTI 치료 2ef46f2986ee8096b55ccd4f633547fb","page_title":"UTI 치료 2ef46f2986ee8096b55ccd4f633547fb","episode":"UTI 치료 2ef46f2986ee8096b55ccd4f633547fb","section_path":["UTI 치료 2ef46f2986ee8096b55ccd4f633547fb"],"source_doc_id":"UTI 치료 2ef46f2986ee8096b55ccd4f633547fb","source_page":null,"source_anchor":"UTI 치료 2ef46f2986ee8096b55ccd4f633547fb-1","focus_area":"UTI Treatment Framework","tags":["usmle-step2","internal-medicine","uti","treatment","table","infectious-disease"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Endocrinology: Thyroid-in-Pregnancy + Neonatal Interface\n## Midline Neck Mass in Child\n- thyroglossal duct cyst로 보이더라도 ectopic thyroid 가능성 먼저 배제.\n- 절제 전 neck ultrasound + thyroid function(TSH/T4) 확인이 필수.\n\n## Maternal-Fetal Thyroid Physiology\n- estrogen 상승으로 TBG 증가 -> total T4 상승 가능.\n- 1st trimester hCG peak는 TSH suppression을 유발할 수 있음.\n\n## Graves in Pregnancy Management Principle\n- maternal overtreatment는 fetal hypothyroidism/goiter 위험.\n- maternal-fetal 균형을 고려한 목표치 설정이 필요.\n\n## Neonatal Thyrotoxicosis\n- maternal TSH receptor antibody transplacental transfer로 발생 가능.\n- tachycardia/irritability/poor weight gain 단서, 대체로 일과성.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-1","focus_area":"Pediatric Endocrine Thyroid Interface","tags":["usmle-step2","pediatrics","endocrinology","thyroid","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Endocrinology: Calcium/Adrenal/Diabetes Pattern Recognition\n## Neonatal Hypocalcemia Scenario\n- seizure + low calcium + 부적절한 PTH 반응에서 maternal physiology(FHH) 역추적이 중요.\n- mother urine calcium 평가가 진단 단서.\n\n## Hypertensive CAH Differential\n| 결핍 효소 | 혈압/전해질 | 성발달 단서 |\n| --- | --- | --- |\n| 11β-hydroxylase deficiency | 고혈압 + 저칼륨 가능 | androgen excess/virilization |\n| 17α-hydroxylase deficiency | 고혈압 + 저칼륨 가능 | sexual infantilism/hypogonadism |\n\n## Pediatric Diabetes Sorting\n- type 1: low/absent C-peptide + autoantibody positive.\n- type 2: 상대적 고인슐린/C-peptide 보존, antibody negative.\n- MODY: strong family history + non-obese + antibody negative.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-21","focus_area":"Pediatric Endocrine Differential","tags":["usmle-step2","pediatrics","endocrinology","cah","diabetes","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Endocrine Recap + Pancreas Framework Entry\n## Rapid Recap\n1. midline neck mass는 수술 전 ectopic thyroid 여부 확인.\n2. 임신 갑상선 해석은 TBG/hCG 생리 변화를 반영.\n3. neonatal hypocalcemia는 maternal metabolic context 포함해 해석.\n4. hypertensive CAH는 11β vs 17α deficiency 패턴으로 구분.\n5. pediatric diabetes는 C-peptide/autoantibody로 subtype 분류.\n\n## Pancreas Operational Framework (Step 2)\n- 당뇨 subtype 구분은 age stereotype보다 biochemical evidence 우선.\n- C-peptide는 endogenous insulin production 지표.\n\n| 항목 | Type 1 DM | Type 2 DM |\n| --- | --- | --- |\n| 핵심 기전 | beta-cell autoimmune destruction | insulin resistance + relative beta-cell dysfunction |\n| C-peptide | 낮음/소실 | 정상~상승(초기) |\n| 항체 | 양성 가능(GAD 등) | 대개 음성 |\n| 임상 맥락 | 급성, DKA 동반 가능 | 점진적, 비만/대사증후군 연관 |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-41","focus_area":"Pediatric Endocrine Recap and Pancreas Entry","tags":["usmle-step2","pediatrics","endocrinology","recap","diabetes","table"]}
